In this week's video, Dr. Brian Durie discusses the first monoclonal antibody approved for myeloma treatment - Darzalex (daratumumab). 

Bottom Line:

Darzalex is a useful drug that has some drawbacks in terms of testing.

Previous Post
ASH 2015: Autologous Transplantation for Multiple Myeloma in the Era of New Drugs
Next Post
#AskDrDurie: What should we know about the FDA approval of ixazomib (Ninlaro®)?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.